Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton

Inflamm Bowel Dis. 2022 Aug 1;28(8):e113. doi: 10.1093/ibd/izac081.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Colitis, Ulcerative*
  • Humans
  • Interferon Type I*
  • Recurrence
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Interferon Type I